---
title: Glomerular Pathology Associated with Nephritic Syndrome
date: "2023-01-22"
enableToc: false
---

> [!info]
>
> ğŸŒ± ä¾†è‡ª: [[Huppert's Notes]]

# Glomerular Pathology Associated with Nephritic Syndrome #ğŸš§ æ–½å·¥ä¸­

### Glomerular Pathology Associated with Nephritic Syndrome

##### Post-streptococcal glomerulonephritis

â€¢Â Â Â Epidemiology: More common in children

â€¢Â Â Â Pathophysiology: Glomerular damage is due to deposition of anti-streptococcal Ab in the glomeruli, so hematuria, hypertension, edema begin 1â€“3 weeks after infection with *Streptococcus* bacteria

â€¢Â Â Â Diagnosis: Anti-streptolysin O may be elevated; low complement

â€¢Â Â Â Treatment: Supportive: Antihypertensives, loop diuretics, steroids if severe; majority of cases self-resolve in weeks to months

##### IgA nephropathy (Berger disease)

â€¢Â Â Â Pathophysiology: Caused by deposition of dysregulated IgA immune complexes

â€¢Â Â Â Clinical features:

-Â Â Â Usually immediately preceded by or co-presenting with respiratory or GI infection (â€œsyn-pharyngiticâ€ hematuria as opposed to post-streptococcal GN, which occurs weeks after pharyngitis); can also be â€œsilentâ€ and go undetected for years

-Â Â Â Manifests as episodic gross hematuria (more common in patients <25 yr) or persistent microscopic hematuria (more common in patients >25 yr)

-Â Â Â Can be primary or secondary to systemic IgA vasculitis

â€¢Â Â Â Diagnosis: Mesangial deposits of predominantly IgA immune complexes on biopsy. Complement levels are often normal.

â€¢Â Â Â Treatment: No effective treatment, some advocate for steroids or fish oil; most patients have good prognosis

##### Membranoproliferative GN

â€¢Â Â Â Pathophysiology: Hypercellularity and thickening of GBM on light microscopy

-Â Â Â Type I (subendothelial GN): Immune complex mediated, typically caused by infections (e.g., HBV, HCV, endocarditis, schistosomiasis)

-Â Â Â Type II (dense deposit disease): Complement mediated, rare, typically in children, but also occurs in adults with monoclonal gammopathy

â€¢Â Â Â Treatment: Treat underlying cause, immunosuppression with steroids if idiopathic

##### Rapidly progressive (crescentic) glomerulonephritis (RPGN)

â€¢Â Â Â Clinical features: Acute decline in renal function over days to weeks due to severe glomerular injury

â€¢Â Â Â Diagnosis: Light microscopy with crescents in >50% of glomeruli due to fibrin formation and macrophages. Pathology and immunopathology distinguish between the three major etiologies:

-Â Â Â **Anti-GBM disease:** Autoantibody to type IV collagen; called Goodpastureâ€™s syndrome when kidney and lung are involved. Linear immunofluorescence. Treatment: Cyclophosphamide, steroids, plasmapheresis.

-Â Â Â **Immune complex disease:** Can be caused by systemic infections (e.g., post-streptococcal glomerulonephritis, infective endocarditis), systemic immune complex disease (e.g., IgA vasculitis, SLE) or primary GN (e.g., IgA nephropathy). Granular immunofluorescence.

-Â Â Â **Pauci-immune disease:** Due to small-vessel vasculitis (GPA, EGPA, MPA) or can be drug-induced (penicillamine, hydralazine). Absence or paucity of glomerular staining for immunoglobulins. Most are ANCA-positive (80%)

